Lv1
100 积分 2023-12-21 加入
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
1天前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
6天前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
6天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
6天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
6天前
已完结
Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ NASH Trial
6天前
已完结
Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity
1个月前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
1个月前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
1个月前
已完结
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
3个月前
已完结
皖公网安备34019202002308
